24/7 Patient Assistance: 760-405-8205

William M. Audeh, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. M. William Audeh is a specialist in medical oncology in West Hollywood, California and he is affiliated with Cedars-Sinai Medical Center. He graduated from University of Iowa Carver College of Medicine where he got his medical degree. He did his residency program in internal medicine at Stanford University and his fellowship in medical oncology at the same institution. The doctor is board certified in internal medicine and medical oncology, and he has a practical experience of more than 20 years.



  • Education & Training

    dept_icon

    University of Iowa Carver College of Medicine

    Medical School

    dept_icon

    Stanford University

    Residency

    dept_icon

    Stanford University

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Cedars-Sinai Medical Center

    Languages: English/Spanish

    (310) 423-3277

    8700 Beverly Blvd

    Los Angeles, California 90048

    Read More
  • Publications & Memberships

    Dr. William M. Audeh has contributed to 3 publications.

    Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.

    Xie, Y.,Collins, W. J.,Audeh, M. W.,Shiao, S. L.,Gottlieb, R. A.,Goodman, M. T.,Merz, C. N.,Mehta, P. K.; Curr Treat Options Cardiovasc Med. 2015 Oct 23.

    See more >>

    Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

    Kaufman B Shapira-Frommer R Schmutzler RK Audeh MW Friedlander M Balmana J Mitchell G Fried G Stemmer SM Hubert A Rosengarten O Steiner M Loman N Bowen K ...; J Clin Oncol. 2015 Jan 20 .

    See more >>

    Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition.

    Audeh MW; Pharmgenomics Pers Med. 2014 .

    See more >>